Development Level

Tbio 2 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

IMPC Term

abnormal embryo size 1 | 112
decreased heart weight 1 | 44
increased circulating glucose ... 1 | 16
increased prepulse inhibition 1 | 21
preweaning lethality, complete... 1 | 633

Disease

Cancer 5 | 2,346
invasive ductal carcinoma 4 | 2,950
pancreatic cancer 4 | 2,300
ductal carcinoma in situ 3 | 1,745
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
medulloblastoma, large-cell 3 | 6,234
ovarian cancer 3 | 8,484
progressive supranuclear palsy 3 | 674
psoriasis 3 | 6,685
subependymal giant cell astrocytoma 3 | 2,287
ulcerative colitis 3 | 2,087
Adenocarcinoma of lung (disorder) 2 | 48
Alzheimer's disease 2 | 644
Anemia 2 | 252
Animal Mammary Neoplasms 2 | 136
Breast cancer 2 | 3,094
Carcinoma 2 | 2,147
Diarrhea 2 | 155
Glioma 2 | 65
Heart disease 2 | 279
Hemochromatosis 2 | 55
Inflammation 2 | 109
Iron deficiency anemia 2 | 6
Iron metabolism disease 2 | 17
Kidney disease 2 | 396
Lung Neoplasms 2 | 171
Malaria 2 | 140
Mammary Neoplasms 2 | 410
Mammary Neoplasms, Experimental 2 | 150
Multiple myeloma 2 | 1,327
Neurodegenerative disease 2 | 383
Obesity 2 | 616
Pick disease 2 | 1,893
Thalassemia 2 | 46
Waldenstrons macroglobulinemia 2 | 765
astrocytic glioma 2 | 2,241
atypical teratoid/rhabdoid tumor 2 | 1,095
breast carcinoma 2 | 1,614
esophageal adenocarcinoma 2 | 737
gastric carcinoma 2 | 832
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
nasopharyngeal carcinoma 2 | 1,056
oligodendroglioma 2 | 2,849
osteosarcoma 2 | 7,933
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
posterior fossa group B ependymoma 2 | 1,530
Adenocarcinoma 1 | 115
Alcohol dependence 1 | 107
Alcoholic Intoxication, Chronic 1 | 41
Angiokeratoma 1 | 9
Aphasia 1 | 22
Barrett's esophagus 1 | 183
Beta thalassemia 1 | 19
Brain disease 1 | 83
Breast disease 1 | 8
Breast fibroadenoma 1 | 8
Cholangiocarcinoma 1 | 32
Chronic Lymphocytic Leukemia 1 | 242
Colorectal Neoplasms 1 | 217
Comedo carcinoma 1 | 2
Drug-Induced Liver Injury 1 | 118
Echinococcosis 1 | 28
Esophageal Neoplasms 1 | 67
Essential tremor 1 | 30
Ewing sarcoma 1 | 26
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Frontotemporal dementia 1 | 41
Gastrointestinal Neoplasms 1 | 4
HER2-positive carcinoma of breast 1 | 10
Hepatitis C 1 | 90
Human immunodeficiency virus infectious disease 1 | 92
Hydrops Fetalis, Non-Immune 1 | 12
Kidney cancer 1 | 118
Leber congenital amaurosis 1 | 72
Liver disease 1 | 219
Lobular neoplasia 1 | 15
Lymphoma, Non-Hodgkin 1 | 22
Lysosomal storage disease 1 | 11
Meningitis 1 | 46
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Neoplasm Recurrence, Local 1 | 23
Neoplastic Cell Transformation 1 | 81
Neutropenia 1 | 78
Papilloma 1 | 27
Pick's disease 1 | 14
Pleomorphic adenoma 1 | 18
Renal Cell Carcinoma 1 | 199
Restless legs syndrome 1 | 28
Thrombocytopenia 1 | 105
Vitamin B12 deficiency 1 | 20
gallbladder neoplasm 1 | 9
locked-in syndrome 1 | 10
non-inflammatory breast cancer 1 | 208
ovarian neoplasm 1 | 97
protein-losing enteropathy 1 | 11

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 3 | 11,971
Enzyme 1 | 4,146
Kinase 1 | 634

Grant Application

5R01CA087990-05 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Serotransferrin TF Tchem Non-IDG -4.13136 13124.3 952
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Receptor tyrosine-protein kinase erbB-2 ERBB2 Tclin Kinase -4.22922 19000.3 3336
RNA-binding protein FUS FUS Tbio Non-IDG -3.13188 1454.2 252
Lysosomal protective protein CTSA Tchem Enzyme -3.09661 1111.1 263